Market Overview:
The global plasma component separator market is expected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing demand for plasma-derived products in hospitals, diagnostic laboratories, pharmaceutical and biotechnological industry, blood banks and research/academic institutes. In addition, technological advancements in membrane plasma separation technique are also propelling the growth of this market. However, high cost of equipment is restraining the growth of this market to some extent. On the basis of type, centrifugation held a dominant position in 2017 and is expected to maintain its dominance during the forecast period as well. This can be attributed to its low cost as compared to other techniques such as filtration and membrane separation technique.
Product Definition:
A plasma component separator is a device used to separate different components in a plasma. The importance of a plasma component separator is that it can help to improve the efficiency and quality of the plasma.
Membrane Plasma Separation Technique:
Plasma component separator is a device used for separation of components in blood plasma. It works on the principle of membrane filtration and uses high pressure and temperature conditions to achieve separation. The Plasma Component Separator market is driven by factors such as rising demand for blood plasma, increasing R&D activities related to product innovation, growing healthcare awareness among people coupled with favorable government initiatives pertaining to the development of healthcare infrastructure in emerging economies including India & China.
Centrifugation:
Centrifugation is the process of separating the liquid from a solid by centrifugal force. It's basically used to separate two phases namely gas and liquid in case of chemical reactions or solution. In case of biological samples, it's used for breaking cell membranes so that cells can die without being able to swim away.
Application Insights:
Based on the application, the market is segmented into hospitals, diagnostic laboratories, pharmaceutical and biotechnological industry, blood banks and research/academic institutes. Hospitals dominated the global plasma component separator market in terms of revenue share in 2017 owing to factors such as increasing healthcare spending by individuals across the globe. Moreover, an increase in hospital construction across various regions coupled with a rise in population is expected to drive demand for equipment over the forecast period.
The diagnostics laboratory segment accounted for a significant share of 21% in 2017 due to factors such as rising prevalence of chronic diseases like cancer which requires regular blood tests and other lab tests that use Plasma Components As Separators (PCAS). Furthermore, growing awareness about personalized medicine through which different types of cells are targeted using their genetic makeup is anticipated to further boost product demand over next eight years.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of industry players, continuous technological advancements, and high adoption rate for advanced technologies across this region. Moreover, increasing government initiatives to develop new plasma component separators are expected to drive regional growth over the forecast period. For instance, in February 2018, The National Institute of Health (NIH) launched a call for applications seeking projects that use innovative approaches to Separation Science under its Emerging Technology Program (ETP).
Asia Pacific is expected to witness lucrative growth during the forecast period owing to untapped opportunities and rapid developments taking place in this region due mainly centrifugal separation techniques along with filtration processes which are highly cost-effective as compared membrane technology’s counterparts especially when it comes about huge volumes involved with blood components processing at low costs.
Growth Factors:
- Increasing demand for plasma-derived therapies and products
- Growing number of patients suffering from chronic diseases
- Technological advancements in plasma fractionation processes
- Rising investments in research and development of new plasma-based therapies
- Growing awareness about the benefits of using plasma-derived therapies
Scope Of The Report
Report Attributes
Report Details
Report Title
Plasma Component Separator Market Research Report
By Type
Membrane Plasma Separation Technique, Centrifugation, Filtration
By Application
Hospitals, Diagnostic Laboratory, Pharmaceutical and Biotechnological Industry, Blood Banks, Research/Academic Institutes
By Companies
B Braun Melsungen, Haemonetics, Fresenius Medical Care, Toray Medical, Terumo, Kawasumi Laboratories, Asahi Kasei Medical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
142
Number of Tables & Figures
100
Customization Available
Yes, the report can be customized as per your need.
Global Plasma Component Separator Market Report Segments:
The global Plasma Component Separator market is segmented on the basis of:
Types
Membrane Plasma Separation Technique, Centrifugation, Filtration
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Diagnostic Laboratory, Pharmaceutical and Biotechnological Industry, Blood Banks, Research/Academic Institutes
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- B Braun Melsungen
- Haemonetics
- Fresenius Medical Care
- Toray Medical
- Terumo
- Kawasumi Laboratories
- Asahi Kasei Medical
Highlights of The Plasma Component Separator Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Membrane Plasma Separation Technique
- Centrifugation
- Filtration
- By Application:
- Hospitals
- Diagnostic Laboratory
- Pharmaceutical and Biotechnological Industry
- Blood Banks
- Research/Academic Institutes
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Plasma Component Separator Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A plasma component separator is a device used to separate components of a gas or liquid mixture by using an electric field.
Some of the major players in the plasma component separator market are B Braun Melsungen, Haemonetics, Fresenius Medical Care, Toray Medical, Terumo, Kawasumi Laboratories, Asahi Kasei Medical.
The plasma component separator market is expected to grow at a compound annual growth rate of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Plasma Component Separator Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Plasma Component Separator Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Plasma Component Separator Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Plasma Component Separator Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Plasma Component Separator Market Size & Forecast, 2020-2028
4.5.1 Plasma Component Separator Market Size and Y-o-Y Growth
4.5.2 Plasma Component Separator Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Membrane Plasma Separation Technique
5.2.2 Centrifugation
5.2.3 Filtration
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Diagnostic Laboratory
6.2.3 Pharmaceutical and Biotechnological Industry
6.2.4 Blood Banks
6.2.5 Research/Academic Institutes
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Plasma Component Separator Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Plasma Component Separator Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Membrane Plasma Separation Technique
9.6.2 Centrifugation
9.6.3 Filtration
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Diagnostic Laboratory
9.10.3 Pharmaceutical and Biotechnological Industry
9.10.4 Blood Banks
9.10.5 Research/Academic Institutes
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Membrane Plasma Separation Technique
10.6.2 Centrifugation
10.6.3 Filtration
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Diagnostic Laboratory
10.10.3 Pharmaceutical and Biotechnological Industry
10.10.4 Blood Banks
10.10.5 Research/Academic Institutes
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Membrane Plasma Separation Technique
11.6.2 Centrifugation
11.6.3 Filtration
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Diagnostic Laboratory
11.10.3 Pharmaceutical and Biotechnological Industry
11.10.4 Blood Banks
11.10.5 Research/Academic Institutes
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Membrane Plasma Separation Technique
12.6.2 Centrifugation
12.6.3 Filtration
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Diagnostic Laboratory
12.10.3 Pharmaceutical and Biotechnological Industry
12.10.4 Blood Banks
12.10.5 Research/Academic Institutes
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Membrane Plasma Separation Technique
13.6.2 Centrifugation
13.6.3 Filtration
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Diagnostic Laboratory
13.10.3 Pharmaceutical and Biotechnological Industry
13.10.4 Blood Banks
13.10.5 Research/Academic Institutes
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Plasma Component Separator Market: Competitive Dashboard
14.2 Global Plasma Component Separator Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 B Braun Melsungen
14.3.2 Haemonetics
14.3.3 Fresenius Medical Care
14.3.4 Toray Medical
14.3.5 Terumo
14.3.6 Kawasumi Laboratories
14.3.7 Asahi Kasei Medical
